Jessica Lam, Author at MedicalAdvancesToday

3 min 0

Healthy gut bacteria can help fight cancer elsewhere in the body

Jessica Lam
July 19, 2023

These findings suggest that a course of antibiotics is detrimental to immune checkpoint inhibitors because gut bacteria can no longer function as immune accelerators.

4 min 0

Research

A 10-year follow-up study of nearly 13,000 people found that regular vitamin D supplementation reduces the risk of dementia by 40%

Jessica Lam
May 22, 2023

The results showed that taking vitamin D reduced the risk of dementia by 40%, resulting in longer dementia-free survival, suggesting vitamin D may become a potential drug for preventing dementia.

7 min 0

Scientists confirmed for the first time that cancer cell PD-L1 does not inhibit T cell toxicity, but inhibits T cell infiltration into metastatic lesions

Jessica Lam
March 24, 2023

After PD-1/PD-L1 inhibitors have been used in cancer immunotherapy for nearly 10 years, scientists are still discovering new mechanisms to replenish our knowledge around PD-L1.

4 min 0

Simufilam, an investigational oral drug for Alzheimer’s Disease, improved cognition in 47% of treated patients in a Phase 2 study

Jessica Lam
March 20, 2023

This single-arm, open-label study showed that 47% of treated patients had a 4.7-point improvement from baseline on the ADAS-Cog score, which assesses cognitive decline, after 1 year of treatment.

2 min 0

Macrophage fumarate hydratase: a novel therapeutic target for inflammatory diseases such as lupus

Jessica Lam
March 19, 2023

Restoring fumarate hydratase or targeting MDA5 or TLR7 in these diseases offers exciting prospects for much-needed new anti-inflammatory therapies.

Author: Jessica Lam

Healthy gut bacteria can help fight cancer elsewhere in the body

A 10-year follow-up study of nearly 13,000 people found that regular vitamin D supplementation reduces the risk of dementia by 40%

Scientists confirmed for the first time that cancer cell PD-L1 does not inhibit T cell toxicity, but inhibits T cell infiltration into metastatic lesions

Simufilam, an investigational oral drug for Alzheimer’s Disease, improved cognition in 47% of treated patients in a Phase 2 study

Macrophage fumarate hydratase: a novel therapeutic target for inflammatory diseases such as lupus

Healthy gut bacteria can help fight cancer elsewhere in the body

Only one mRNA vaccine shot can reduce HPV-related tumors, and the effect is better than DNA or recombinant protein vaccines

A 10-year follow-up study of nearly 13,000 people found that regular vitamin D supplementation reduces the risk of dementia by 40%

Researchers revealed the B cell mechanism of autoimmunity triggered by the clearance of susceptible macrophages in lymph nodes

A phase 1 clinical study showed a small molecule drug targeting lipoprotein (a) can reduce its level by 65%

For the first time in 20 years, FDA fully approved a new drug for Alzheimer’s disease

Scientists have discovered a novel target for Alzheimer’s Disease and the clinical results are astounding

Simufilam, an investigational oral drug for Alzheimer’s Disease, improved cognition in 47% of treated patients in a Phase 2 study

A phase 1 clinical study showed a small molecule drug targeting lipoprotein (a) can reduce its level by 65%

Scientists have discovered a novel target for Alzheimer’s Disease and the clinical results are astounding

Simufilam, an investigational oral drug for Alzheimer’s Disease, improved cognition in 47% of treated patients in a Phase 2 study